China News Service, February 7th. According to Reuters, on the 7th local time, the British "Financial Times" published a report stating that studies by the University of Kingsoft in South Africa and the University of Oxford in the UK showed that the AstraZeneca vaccine is effective against the mutant virus appearing in South Africa. Significantly reduced.
Subsequently, the British pharmaceutical company AstraZeneca responded.
Data map: EU medical staff are preparing for new crown vaccination.
According to reports, an AstraZeneca spokesperson said in response to a report in the Financial Times, “According to a small-scale trial, its early data showed that affected by the mutant new coronavirus discovered in South Africa, (vaccine) had mild symptoms. The effect of the person is limited".
However, the spokesperson said: “Considering that the subjects are mainly healthy young adults, we are still not sure about its (vaccine) effect on serious diseases and hospitalization.” At the same time, AstraZeneca also said that in view of the vaccine The neutralizing antibody activity of AstraZeneca is equivalent to other new coronavirus vaccines that have been proven to protect against serious diseases. It is believed that the AstraZeneca vaccine can prevent severe illness.
At present, Oxford University and AstraZeneca have begun to adjust vaccines against mutant viruses, and will rapidly advance through clinical development so that they can be put into production in the fall.